Development and optimization of multivesicular gefitinib liposomal transdermal system employing lipoid S100 for breast cancer: pharmacokinetics, bioavailability, and skin irritation studies in Wistar rats
Abstract Background Conventional therapies in cancer treatment face challenges including drug resistance, lack of specificity, and severe adverse reactions. This study explores the potential of liposomal transdermal delivery systems as an alternative to current therapies with improved BA and PK. The...
Saved in:
Main Authors: | Jyoti S. Patel (Author), Nulgumnalli Manjunathaiah Raghavendra (Author), B. Sajeev Kumar (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multivesicular Liposomes for Glucose-Responsive Insulin Delivery
by: Guangqu Liu, et al.
Published: (2021) -
Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization
by: Hongjie Mu, et al.
Published: (2018) -
Optimized formulation of multivesicular liposomes loaded with oleanolic acid enhanced anticancer effect in vitro
by: Wang Y, et al.
Published: (2017) -
Impact of particle size of multivesicular liposomes on the embolic and therapeutic effects in rabbit VX2 liver tumor
by: Hailing Tang, et al.
Published: (2023) -
Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats
by: Hajer AlRasheed, et al.
Published: (2022)